Bengisu Ay

Dr. Bengisu Ay is a specialist in infectious diseases and clinical microbiology at Medipol University Pendik Hospital. She treats viral conditions, including Hepatitis C and Viral Hepatitis. Dr. Ay has contributed to multi-center research on antibiotic resistance and diabetic foot infections.

Specialization and Medical Focus

Dr. Ay treats a variety of infectious diseases and provides chronic viral care. She treats patients with Hepatitis B and C using antiviral therapies. The doctor also treats diabetic foot wounds and related bacterial complications. Her diagnostic work includes laboratory testing for HIV and Human Papillomavirus (HPV).

Clinical Experience

• 2017 – 2020: Acipayam State Hospital, Turkey
• 2016 – 2017: Izmir Public Health Laboratory
• 2013 – 2016: Bozyaka Training and Research Hospital
• 2011 – 2013: Pendik State Hospital
• 2011 – 2011: Midyat State Hospital
• 2004 – 2010: Dokuz Eylul University Faculty of Medicine

Education and Training

• 2010: Dokuz Eylul University Faculty of Medicine – Specialty in Infectious Diseases and Clinical Microbiology
• 2004: Ege University Faculty of Medicine – Medical Degree

Research and Publications

Dr. Ay publishes research in national and international peer-reviewed journals. She participated in the Turk-Day Working Group to study diabetic foot pathogens. Her work also includes case reports on rare infections and drug side effects. Furthermore, she contributed to a clinical study regarding Aeromonas hydrophila in total knee arthroplasty perioperative cultures.

Selected Publications

• "Intralesional epidermal growth factor for diabetic foot wounds: the first cases in Turkey"
• "Causative pathogens and antibiotic resistance in diabetic foot infections: A prospective study"
• "A small outbreak of Serratia liquefaciens bacteremia due to contaminated saline solution"
• "Atypical Mediterranean spotted fever: First case from Aegean Region"
• "Telbivudine-Related Myopathy: A Case Report"
• "Evaluation of the knowledge level and vaccination status of individuals in the risk group recommended for influenza vaccination"

Scientific Presentations

• 2015: 5th EKMUD Scientific Platform, Izmir – Research on antimicrobial susceptibility
• 2015: Congress of Balkan Military Medical Committee, Greece – Presentation on bacterial etiology
• 2015: BUHASDER 6th Tepecik Infection Days Symposium – Study on Hepatitis B transmission knowledge levels
• 2014: 12th National Viral Hepatitis Congress – Reports on telaprevir and telbivudine
• 2013: 5th National Vaccine Symposium, Ankara – Influenza vaccination status study
• 2013: Our Turkey Teleprevir Experience Symposium – Evaluation of 4 patients receiving telaprevir for chronic Hepatitis C